HeartWare HVAD Pump Implant Kit (Heartware Ventricular Assist Device) - HeartWare Battery For use as a bridge-to-cardiac transplantation in patients who are at risk of death from refractory end-stage ventricular heart failure.The HeartWare VAS is designed for in-hospital and out-of-hospital settings, including transportation via fix-wing aircraft or helicopter.
Publicado el 21 de mayo de 2014 · Inicio del retiro: 16 de abril de 2014
Resumen
FDA registra el retiro Z-1607-2014 de dispositivos médicos de Clase II, publicado el 21 de mayo de 2014 e iniciado el 16 de abril de 2014. Empresa responsable: HeartWare Inc; Estado: Finalizado; Cantidad reportada: 32,349; Lote: Catalog# USA:1650 // OUS: 1650, 1650-DE All HeartWare Battery Serial Numbers. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.
Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
Patients and caregivers are instructed that if a battery does not provide two hours of support or behaves unusually, that battery should no longer be used and should be replaced.
Qué hacer
Voluntary: Firm initiated · Letter
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- HeartWare Inc
- Distribuidor
- Worldwide Distribution - USA including AL, AZ, CA, CO, CT, DE, FL, GA, HI, IL, IN, KY, LA, MA, MD, MI, MN, MO, NJ, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, WY, District of Columbia and Internationally to Canada, Dominican Republic, Australia, Belgium, Italy, Germany, New Zeland, South Afica, Japan, Venezuela, Czech Republic, France, Switzerland, Brazil, UK, Saui Arabia, Taiwan, Slovakia, Luxemburg, Hong Kong, Lebano, India, Chile, Oldenburg, Israel, Netherlands, Croatia, Egypt, Turkey, Malaysia, Norway, Greece, Spain, Lithuania, Korea, Singapore, Poland, and Argentina.
- Lote
- Catalog# USA:1650 // OUS: 1650, 1650-DE All HeartWare Battery Serial Numbers
- Clasificación de riesgo
- Class II
- Área (FDA)
- device
- País
- United States
Retiros relacionados
- FDAHeartWare Ventricular Assist System (HVAD) For use as a bridge-to-cardiac transplantation in patient who are17 de junio de 2015
- FDAHeartWare Ventricular Assist System (HeartWare Controller) Product Usage: For use as a bridge-to-cardiac4 de marzo de 2015
- FDATennis Elbow Support, Neoprene***LATEX FREE" Product Usage: Provides compression and warmth for mild to21 de mayo de 2014
- FDAUltrasound needles, 22G (0.7 mm) x 50mm, packaged individually, 10 needles/box, item number REF USC050-22.21 de mayo de 2014
- FDAHeartware HVAD Pump Implant Kit (Heartware Ventricular Assist Device) Catalog Numbers: 1100, 1101, 1102, 1103,30 de abril de 2014
- FDAHeartware HVAD Pump Implant Kit (Heartware Ventricular Assist Device)7 de agosto de 2013
Preguntas sobre este retiro
¿HeartWare HVAD Pump Implant Kit (Heartware Ventricular Assist Device) - HeartWare Battery For use as a bridge-to-cardiac transplantation in patients who are at risk of death from refractory end-stage ventricular heart failure.The HeartWare VAS is designed for in-hospital and out-of-hospital settings, including transportation via fix-wing aircraft or helicopter. fue retirado del mercado?
Sí. FDA publicó el retiro Z-1607-2014 el 21 de mayo de 2014. Peligro reportado: Patients and caregivers are instructed that if a battery does not provide two hours of support or behaves unusually, that battery should no longer be used and should be replaced.
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Letter